However, since no such monoclonal antibody is available, the current assay can also provide sufficient information about TAC effects on NFAT functioning, since the induced NFATc1/A molecules contribute to the NFAT pathway as a positive feedback loop. This evidence concerns the gene NFATC1 and persistent truncus arteriosus.